Supreme Court ends India's largest bank fraud case against Sterling Group after promoters offer Rs 5,100 crore settlement. All civil and criminal proceedings quashed upon deposit completion by December 2025.
Odisha's Science Dept invites faculty & researchers for biotech R&D grants up to Rs 30 lakh. Maximum 10 projects selected yearly. Submit applications before December 10 deadline.
Sterling Kodai Valley introduces India's first cycle-themed suites promoting slow travel. Experience unique cycling decor and curated routes in Kodaikanal. Book now for sustainable tourism!
British government announces massive $30+ billion tax increase as economic outlook worsens. Pound sterling and bonds experience volatility following budget revelation. Read full analysis.
Three-year-old Sterling becomes NBA sensation after shy Jumbotron appearance goes viral with 50M views. The 'Popcorn Kid' returns for encore performance that outshines game action.
Brittany Mahomes shares adorable family photos from Chiefs game with her three children Sterling, Bronze and Golden. See the emotional reunion with Patrick Mahomes after victory.
Fugitive Sandesara brothers offer Rs 5,100 crore settlement, bringing total recovery to Rs 9,800 crore - far exceeding banks' Rs 6,700 crore demand. ED celebrates biggest PMLA recovery.
Get all the details on the upcoming mystery drama 'Is God Is'. Starring Sterling K. Brown and Janelle Monae, it releases on May 15, 2026. Don't miss it!
Supreme Court permits Sandesara brothers to settle massive bank fraud case with ₹5,100 crore payment. Historic decision marks first criminal case closure after settlement. Read full details.
Supreme Court approves ₹5,100 crore settlement by fugitive Sandesara brothers in massive bank fraud case. All criminal proceedings to be dropped upon payment completion by December 2025.
Supreme Court agrees to drop criminal proceedings against Sterling Biotech promoters in bank fraud case upon payment of Rs 5,100 crore by December 17, 2025. Full case details inside.
India's biotechnology sector is projected to become a $1.2 trillion industry by 2047, driven by vaccines, diagnostics, and bio-agriculture. Discover how this growth will transform healthcare and agriculture.
A US commission warns Congress of China's growing leverage in biotech, quantum computing, and legacy semiconductors, urging action to prevent supply chain weaponization. Read the full report.
Dollar strengthens against euro while Fed rate cut probability drops to 41%. Market volatility expected as US economic data resumes post-shutdown. Pound tumbles on UK tax policy shift.
British Pound strengthens against major currencies ahead of Bank of England policy meeting, while Norwegian Krone climbs as Norway's central bank maintains current interest rates. Market analysis and currency outlook included.
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
The UFC 321 controversy intensifies as Aljamain Sterling stands firm on his explosive comments about Tom Aspinall's eye poke incident. Get the latest on the brewing storm in MMA.
Sterling faces severe pressure as it tumbles to weakest levels in months against USD and hits years-low against EUR. Federal Reserve's hawkish stance and UK economic concerns drive the decline.
Kansas City Chiefs quarterback Patrick Mahomes shares heartwarming Halloween details about family costumes chosen by his son and wife Brittany's festive leadership in exclusive interview.
In a significant setback for gene editing medicine, Intellia Therapeutics halts its Phase 3 ATTR trial following a serious liver adverse event in a patient receiving CRISPR-based treatment NZ-1.
Swiss pharmaceutical giant Novartis AG is finalizing a landmark acquisition of California-based Avidity Biosciences in a deal valuing the biotech firm at over $70 per share, potentially exceeding $1.7 billion, according to exclusive reports.